ViciniVax BV
PrivateLast Round
VC Round
Jul 1, 2026
Company Overview
ViciniVax BV is a clinical-stage biopharmaceutical company that develops therapeutic cancer vaccines for the treatment of HPV-related premalignant lesions and cervical cancer.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Clinical Trials, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
ViciniVax BV Comparables
Compare ViciniVax BV with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Barinthus Biotherapeutics | 78% | |
| PDS Biotechnology Corp | 78% | |
| Nykode Therapeutics | 77% | |
ViciniVax BV Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| VC Round | Jul 1, 2026 |
ViciniVax BV Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| RuG Ventures | Seed |
| Hanzepoort B.V. | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Nov 11, 2025
Monthly visitors increased 135% MoM, reaching 2.1K.
ViciniVax BV Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about ViciniVax BV's valuation, stock price, and market status.